Skip to main content
. 2010 Nov 5;77(1):148–155. doi: 10.1128/AEM.01676-10

TABLE 4.

Comparison of antimicrobial resistance between integron-positive (n = 100) and integron-negative (n = 100) E. coli isolatesa

Antimicrobial agent Resistance frequency (%)
Mean % χ2 P value
Integron-positive isolates (n = 100) Integron-negative isolates (n = 100)
Aminoglycosides
    GM 20 25 22.5 0.1 >0.05
    STR 50 37 43.5 2.93 >0.05
    NN 15 6 10.5 4.5 <0.05
Cephalosporins
    CFP 31 15 23 6.35 <0.05
    CRO 26 27 26.5 0 >0.05
    CZ 37 54 40.5 5.16 <0.05
β-Lactams
    AM 75 71 73 0.23 >0.05
Quinolones
    CIP 36 19 27.5 6.42 <0.05
    NOR 36 6 21 27.12 <0.05
Macrolides
    AZM 36 22 29 4.1 <0.05
Tetracyclines
    TE 71 67 69 0.21 >0.05
Sulfonamides
    SXT 46 36 41 1.67 >0.05
Rifamycins
    RA 96 79 87.5 11.7 <0.05
Phenicols
    CHL 79 84 81.5 0.67 >0.05
Carbapenem
    IPM 0 0 0
Lipopeptide
    PB 2 8 5 2.63 >0.05
Nitrofuran
    F/M 33 46 39.5 3.01 >0.05
a

Differences in resistance between the two groups were established using the χ2 test and were considered significant at a P value of <0.05.